Medicenna Therapeutics to Announce Second Quarter 2022 Financial Results and Operational Highlights on Friday, November 12, 2021

NEXT STORY
Akoya Biosciences to Present Data at SITC 2021 Highlighting Novel Spatial Biology Applications
PREV STORY
Global Active Pharmaceutical Ingredients (API) Markets, 2021-2026 – Invention Of New Generation APIs & Growth In API Outsourcing Operations
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Pfizer und BioNTech erhalten positive CHMP-Empfehlung für ihren COVID-19-Impfstoff

author_avatar
NASDAQ Market News

Novartis investigational BYL719 (alpelisib) plus fulvestrant consistently improved PFS in patients with PIK3CA mutated HR+/HER2- advanced breast cancer in new SOLAR-1 analyses

BYL719 plus fulvestrant meaningfully prolonged PFS vs fulvestrant alone in patients with PIK3CA mutated ...

author_avatar
NASDAQ Market News

NaturalShrimp, Inc. Announces Nominations for Board of Director Positions

author_avatar
NASDAQ Market News